RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.370
-0.030 (-2.14%)
At close: Jan 6, 2026, 4:00 PM EST
1.320
-0.050 (-3.65%)
After-hours: Jan 6, 2026, 7:55 PM EST
RedHill Biopharma Employees
RedHill Biopharma had 35 employees as of December 31, 2024. The number of employees decreased by 18 or -33.96% compared to the previous year.
Employees
35
Change (1Y)
-18
Growth (1Y)
-33.96%
Revenue / Employee
$272,857
Profits / Employee
-$266,086
Market Cap
6.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35 | -18 | -33.96% |
| Dec 31, 2023 | 53 | -60 | -53.10% |
| Dec 31, 2022 | 113 | -88 | -43.78% |
| Dec 31, 2021 | 201 | 19 | 10.44% |
| Dec 31, 2020 | 182 | 27 | 17.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RDHL News
- 9 hours ago - What's Going On With Redhill Biopharma Stock On Tuesday? - Benzinga
- 1 day ago - RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects - PRNewsWire
- 22 days ago - RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells - PRNewsWire
- 5 weeks ago - RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement - PRNewsWire
- 2 months ago - RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement - PRNewsWire
- 2 months ago - RedHill Biopharma Receives Nasdaq Staff Determination Notification - PRNewsWire
- 2 months ago - CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO - PRNewsWire
- 3 months ago - RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia® - PRNewsWire